This company has been marked as potentially delisted and may not be actively trading. Xyratex (XRTX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesShort InterestTrendsBuy This Stock XRTX vs. ABVC, TXMD, IMNN, MRKR, SYBX, LSB, RLMD, QNTM, PHIO, and NERVShould you be buying Xyratex stock or one of its competitors? The main competitors of Xyratex include ABVC BioPharma (ABVC), TherapeuticsMD (TXMD), Imunon (IMNN), Marker Therapeutics (MRKR), Synlogic (SYBX), Lakeshore Biopharma (LSB), Relmada Therapeutics (RLMD), Quantum Biopharma (QNTM), Phio Pharmaceuticals (PHIO), and Minerva Neurosciences (NERV). These companies are all part of the "pharmaceutical preparations" industry. Xyratex vs. ABVC BioPharma TherapeuticsMD Imunon Marker Therapeutics Synlogic Lakeshore Biopharma Relmada Therapeutics Quantum Biopharma Phio Pharmaceuticals Minerva Neurosciences ABVC BioPharma (NASDAQ:ABVC) and Xyratex (NASDAQ:XRTX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, community ranking, analyst recommendations, earnings and valuation. Is ABVC or XRTX more profitable? Xyratex has a net margin of 0.00% compared to ABVC BioPharma's net margin of -1,619.65%. ABVC BioPharma's return on equity of -104.94% beat Xyratex's return on equity.Company Net Margins Return on Equity Return on Assets ABVC BioPharma-1,619.65% -104.94% -56.81% Xyratex N/A -146.27%-86.83% Does the MarketBeat Community prefer ABVC or XRTX? Xyratex received 156 more outperform votes than ABVC BioPharma when rated by MarketBeat users. CompanyUnderperformOutperformABVC BioPharmaN/AN/AXyratexOutperform Votes15663.41% Underperform Votes9036.59% Do institutionals & insiders believe in ABVC or XRTX? 11.4% of ABVC BioPharma shares are held by institutional investors. Comparatively, 0.2% of Xyratex shares are held by institutional investors. 11.9% of ABVC BioPharma shares are held by company insiders. Comparatively, 6.9% of Xyratex shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has higher earnings & valuation, ABVC or XRTX? Xyratex has lower revenue, but higher earnings than ABVC BioPharma. ABVC BioPharma is trading at a lower price-to-earnings ratio than Xyratex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioABVC BioPharma$509.59K32.82-$10.52M-$0.47-2.26XyratexN/AN/A-$2.16M-$1.35-0.76 Does the media favor ABVC or XRTX? In the previous week, ABVC BioPharma had 1 more articles in the media than Xyratex. MarketBeat recorded 2 mentions for ABVC BioPharma and 1 mentions for Xyratex. ABVC BioPharma's average media sentiment score of 0.46 beat Xyratex's score of 0.00 indicating that ABVC BioPharma is being referred to more favorably in the media. Company Overall Sentiment ABVC BioPharma Neutral Xyratex Neutral Which has more volatility & risk, ABVC or XRTX? ABVC BioPharma has a beta of 0.33, suggesting that its stock price is 67% less volatile than the S&P 500. Comparatively, Xyratex has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500. SummaryABVC BioPharma beats Xyratex on 8 of the 13 factors compared between the two stocks. Get Xyratex News Delivered to You Automatically Sign up to receive the latest news and ratings for XRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XRTX vs. The Competition Export to ExcelMetricXyratexPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.87M$6.89B$5.56B$7.82BDividend YieldN/A3.05%5.11%4.22%P/E Ratio-0.767.4422.5118.48Price / SalesN/A242.70395.68103.60Price / CashN/A65.8538.1834.62Price / Book0.446.516.774.25Net Income-$2.16M$143.21M$3.22B$248.23M Xyratex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XRTXXyratex0.5626 of 5 stars$1.02-0.5%N/A-59.8%$3.87MN/A-0.76N/AHigh Trading VolumeABVCABVC BioPharma1.0933 of 5 stars$0.83-4.7%N/A-15.2%$13.12M$509,788.00-0.9730Earnings ReportTXMDTherapeuticsMD1.77 of 5 stars$1.11+11.4%N/A-34.0%$12.85M$1.76M0.00420Analyst ForecastGap DownIMNNImunon2.7241 of 5 stars$0.87-1.9%$21.50+2,365.6%-35.9%$12.75M$500,000.00-0.4630Short Interest ↓MRKRMarker Therapeutics4.5534 of 5 stars$1.19-0.8%$13.17+1,006.4%-70.6%$12.74M$6.59M-0.9960Short Interest ↓Positive NewsSYBXSynlogic2.4441 of 5 stars$1.09+2.7%N/A-36.3%$12.74M$8,000.00-0.2680Short Interest ↓Positive NewsGap DownLSBLakeshore Biopharma1.3978 of 5 stars$1.36+5.9%N/AN/A$12.61M$672.27M0.00773Short Interest ↓Positive NewsRLMDRelmada Therapeutics4.2749 of 5 stars$0.38+17.0%$4.25+1,024.3%-91.1%$12.55MN/A-0.1310Upcoming EarningsGap DownHigh Trading VolumeQNTMQuantum BiopharmaN/A$6.28+0.6%N/AN/A$12.05MN/A-0.41N/AUpcoming EarningsGap DownPHIOPhio Pharmaceuticals2.5269 of 5 stars$2.51-11.3%$4.00+59.4%-69.4%$11.99MN/A-0.2310Upcoming EarningsGap DownNERVMinerva Neurosciences3.6794 of 5 stars$1.71+3.0%$5.00+192.4%-29.2%$11.96MN/A-3.899Negative News Related Companies and Tools Related Companies ABVC Alternatives TXMD Alternatives IMNN Alternatives MRKR Alternatives SYBX Alternatives LSB Alternatives RLMD Alternatives QNTM Alternatives PHIO Alternatives NERV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XRTX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xyratex Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Xyratex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.